These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36863566)

  • 81. To prophylax or not, and how much and how long? Controversies in VTE prevention for medical inpatients, including COVID-19 inpatients.
    Spyropoulos AC
    Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):506-514. PubMed ID: 36485109
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Cost-effectiveness of prophylactic low molecular weight heparin in pregnant women with a prior history of venous thromboembolism.
    Johnston JA; Brill-Edwards P; Ginsberg JS; Pauker SG; Eckman MH
    Am J Med; 2005 May; 118(5):503-14. PubMed ID: 15866253
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Screening and prevention of venous thromboembolism in critically ill patients: a decision analysis and economic evaluation.
    Sud S; Mittmann N; Cook DJ; Geerts W; Chan B; Dodek P; Gould MK; Guyatt G; Arabi Y; Fowler RA; ;
    Am J Respir Crit Care Med; 2011 Dec; 184(11):1289-98. PubMed ID: 21868500
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia.
    Rank CU; Lynggaard LS; Als-Nielsen B; Stock W; Toft N; Nielsen OJ; Frandsen TL; Tuckuviene R; Schmiegelow K
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013399. PubMed ID: 33038027
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Cost-effectiveness of prolonged thromboprophylaxis after cancer surgery.
    Bradley CT; Brasel KJ; Miller JJ; Pappas SG
    Ann Surg Oncol; 2010 Jan; 17(1):31-9. PubMed ID: 19707830
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
    Rasmussen MS; Jørgensen LN; Wille-Jørgensen P
    Cochrane Database Syst Rev; 2009 Jan; (1):CD004318. PubMed ID: 19160234
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Enoxaparin for thromboprophylaxis after major trauma: potential cost implications.
    Shorr AF; Ramage AS
    Crit Care Med; 2001 Sep; 29(9):1659-65. PubMed ID: 11546959
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Stratification of venous thromboembolism risk in burn patients by Caprini score.
    Li Q; Ba T; Wang LF; Chen Q; Li F; Xue Y
    Burns; 2019 Feb; 45(1):140-145. PubMed ID: 30253959
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Extended pharmacologic thromboprophylaxis in oncologic liver surgery is safe and effective.
    Kim BJ; Day RW; Davis CH; Narula N; Kroll MH; Tzeng CWD; Aloia TA
    J Thromb Haemost; 2017 Nov; 15(11):2158-2164. PubMed ID: 28846822
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Extended thromboprophylaxis in the acutely ill medical patient after hospitalization - a paradigm shift in post-discharge thromboprophylaxis.
    Mahan CE; Burnett AE; Fletcher ML; Spyropoulos AC
    Hosp Pract (1995); 2018 Feb; 46(1):5-15. PubMed ID: 29171776
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The effect of physician educational intervention on venous thromboembolism pharmacological prophylaxis in medical inpatients from the respiratory department: a retrospective cohort study.
    Wang H; Pan Y; Chen T; Chen L; Lv H; Chen E; Qu J; Tang W; Xu W; Lu Y
    Ann Palliat Med; 2020 Nov; 9(6):3966-3975. PubMed ID: 33302659
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Clinical experience with bemiparin.
    Abad Rico JI; Lozano Sánchez FS; Rocha E
    Drugs; 2010 Dec; 70 Suppl 2():25-33. PubMed ID: 21162607
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Is thromboprophylaxis cost effective in ovarian hyperstimulation syndrome: A systematic review and cost analysis.
    Wormer KC; Jangda AA; El Sayed FA; Stewart KI; Mumford SL; Segars JH
    Eur J Obstet Gynecol Reprod Biol; 2018 May; 224():117-124. PubMed ID: 29602141
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Efficacy and safety of high-dose thromboprophylaxis in morbidly obese inpatients.
    Wang TF; Milligan PE; Wong CA; Deal EN; Thoelke MS; Gage BF
    Thromb Haemost; 2014 Jan; 111(1):88-93. PubMed ID: 24136071
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Venous thromboembolism prophylaxis in patients hospitalized in medical wards: A real life experience.
    Mahlab-Guri K; Otman MS; Replianski N; Rosenberg-Bezalel S; Rabinovich I; Sthoeger Z
    Medicine (Baltimore); 2020 Feb; 99(7):e19127. PubMed ID: 32049830
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Antithrombotic Therapy for Venous Thromboembolism and Prevention of Thrombosis in Otolaryngology-Head and Neck Surgery: State of the Art Review.
    Cramer JD; Shuman AG; Brenner MJ
    Otolaryngol Head Neck Surg; 2018 Apr; 158(4):627-636. PubMed ID: 29484922
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Risk factors for inpatient venous thromboembolism despite thromboprophylaxis.
    Wang TF; Wong CA; Milligan PE; Thoelke MS; Woeltje KF; Gage BF
    Thromb Res; 2014 Jan; 133(1):25-9. PubMed ID: 24300584
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Prediction and Prevention of Cancer-Associated Thromboembolism.
    Khorana AA; DeSancho MT; Liebman H; Rosovsky R; Connors JM; Zwicker J
    Oncologist; 2021 Jan; 26(1):e2-e7. PubMed ID: 33274815
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The cost-effectiveness and cost-utility analysis of the use of enoxaparin compared with heparin for venous thromboembolism prophylaxis in medical inpatients in Iran.
    Amirsadri M; Mousavi S; Karimipour A
    Daru; 2019 Dec; 27(2):627-634. PubMed ID: 31368091
    [TBL] [Abstract][Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.